Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock
Med Page Today
APRIL 9, 2024
(MedPage Today) -- ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than 350 patients receiving.
Let's personalize your content